Simple gene technique changes sex of a mouse
By Steve Connor,
The Independent
| 12. 11. 2009
From Minnie to Mickey (and all they did was turn off a gene)
The battle of the sexes is a never-ending war waged within ourselves
as male and female elements of our own bodies continually fight each
other for supremacy. This is the astonishing implication of a
pioneering study showing that it is possible to flick a genetic switch
that turns female ovary cells into male testicular tissue.
For
decades, the battle of the sexes has been accepted by biologists as a
real phenomenon with males and females competing against each other -
when their interests do not coincide - for the continued survival of
their genes in the next generation. Now scientists have been able to
show that a gender war is constantly raging between the genes and cells
of one individual.
One of the great dogmas of biology is that
gender is fixed from birth, determined by the inheritance of certain
genes on the X and Y sex chromosomes. But this simplistic idea has been
exploded by the latest study, which demonstrated that fully-developed
adult females can undergo a partial sex change following a genetic
modification to a single gene.
The...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
